Back to search

Article

Carvacrol suppressed LIHC via SLC6A3

2022-02-18

Abstract excerpt

<h4>Background: </h4> Liver hepatocellular carcinoma (LIHC) is the second leading cause of tumor-related death in the world and its study is urgent. Carvacrol was also found to inhibit multiple cancer types. Here we proposed that carvacrol inhibited LIHC.MethodsWe used MTT assay to determine the inhibition of carvacrol on LIHC cells. BATMAN-TCM was used to predict targets of carvacrol. These targets were further s...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
600d136f-83e6-5321-b983-e2ab5b300b7a
DOI
10.21203/rs.3.rs-1372606/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Carvacrol suppressed LIHC via SLC6A3DOI 10.21203/rs.3.rs-1372606/v1
Vesicle amine transport-1 regulates hepatocellular carcinoma progression by EGF-induced STAT3 signallingSemantic proximity
Integrated transcriptomic analyses identifies host-targeting repurposing drugs for hepatitis C virus infection and related hepatocellular carcinomaSemantic proximity
Uncovering the Mechanism of Shenlian Capsules in the Treatment of Non-small Cell Lung Cancer by System PharmacologySemantic proximity
In vitro study on reversible regulation of CAR-T function by kinsenosideSemantic proximity
A Novel Liver Cancer-Selective Histone Deacetylase Inhibitor Is Effective Against Hepatocellular Carcinoma and Induces Durable Responses with ImmunotherapySemantic proximity
CLDN4 palmitoylation promotes hepatic-to-biliary lineage transition and lenvatinib resistance in hepatocellular carcinomaSemantic proximity
Identification of an m6A Natural Inhibitor, Lobeline, That Reverses Lenvatinib Resistance in Hepatocellular TumorsSemantic proximity
Elucidating the Multi-Target Mechanisms of Niclosamide in Hepatocellular Carcinoma through Network Pharmacology, Molecular Docking, and Molecular Dynamics SimulationsSemantic proximity
Target prediction and potential application of dihydroartemisin on hepatocarcinomaSemantic proximity
Itaconate promotes hepatocellular carcinoma progression by epigenetic induction of CD8+ T-cell exhaustionSemantic proximity
Targeting the LY6H-PI3K/AKT Autophagy Axis Suppresses HCC Malignancy and Reveals a Druggable VulnerabilitySemantic proximity
Targeting VCX2 in Hepatocellular Carcinoma: An Omics-Guided Druggability Study Using Peruvian Natural ProductsSemantic proximity
Select a neighboring publication to make it the new centre.